Rick Simpson Oil (RSO) in Tipton County, Indiana: The Complete Guide by OilWell Cannabis

Rick Simpson Oil changed everything about how people think about concentrated cannabis. If you’re here in Tipton County searching for real answers about RSO, you’re not alone. We know the journey that brought you here — maybe it’s chronic pain that the prescriptions in your medicine cabinet stopped touching years ago. Maybe it’s a cancer diagnosis, and you’re looking for anything that might help alongside the treatments at IU Health or Community Howard Regional. Maybe you’re a veteran in Tipton County struggling with PTSD after serving our country, and the VA options haven’t delivered the relief you need. Maybe you’re a caregiver in Sharpsville or Kempton watching someone you love suffer, and you’re looking for something that actually works.

Whatever brought you here, we built this guide for you. Not for search engines. Not for hype. For the real people of Tipton County who need honest, science-based information about what RSO is, what it can and cannot do, and how our formula — developed through a decade of real-world formulation, tested on the founder’s own dog and his own PTSD, validated by seven ABC13 news features in Houston — might fit your specific situation.

We are OilWell Cannabis, based in Houston, Texas. We don’t have a physical store in Tipton County — but we serve Tipton County every single day through same-day shipping that reaches your door in rural Indiana as reliably as it reaches downtown Indianapolis. We built our RSO formula because the original Rick Simpson approach, while historically important, had real problems. We’ve solved those problems through multi-cannabinoid science, patient-controlled potency, and complete transparency. And yes, we publish our entire formula publicly, because we believe the people of Tipton County deserve to know exactly what they’re putting in their bodies.

This is the most comprehensive RSO education available anywhere. It’s built on 29 peer-reviewed research citations, six primary sources on Rick Simpson himself, and seven major-network news features. No competitor in Indiana — or anywhere else — provides this depth. Use it. Share it. And if you have questions that aren’t answered here, call us at (832) 416-2816. We actually answer.

Why Tipton County Residents Are Searching for RSO

Tipton County is a special place. You know your neighbors. You value honesty. You work hard. And you don’t have time for nonsense. When the local clinic in Tipton can’t solve a medical problem, you drive to Kokomo or Indianapolis. When the specialist there prescribes something that doesn’t work or causes side effects worse than the condition itself, you start looking for alternatives.

We’ve been serving Tipton County residents long enough to understand the pattern. The opioid crisis hit Indiana hard — including rural counties like Tipton. Purdue Pharma’s aggressive marketing touched every corner of the state. If you’re one of the thousands of Hoosiers who got caught in that cycle, or if you’re dealing with chronic pain after a workplace injury at one of Tipton County’s manufacturing plants or farms, you’re not interested in another pill that might addict you. You’re looking for something that addresses pain at its source without destroying your life.

Cancer patients in Tipton County face a different challenge. You might be driving to the IU Health Simon Cancer Center in Indianapolis, or maybe to Community Howard Regional for treatment. The chemo helps, but the side effects — nausea, weight loss, insomnia, anxiety — can be brutal. Your oncologist might not mention cannabis, but your neighbor who survived breast cancer might be telling you about RSO at church. That’s why you’re here.

PTSD is real in Tipton County. Veterans who served in Iraq and Afghanistan come home to a community that supports them, but the VA system is overwhelmed. The nightmares don’t stop. The hypervigilance makes it hard to work. The anxiety makes family life difficult. Prescription after prescription gets thrown at the problem, but the side effects — sedation, weight gain, emotional numbing — can be as bad as the PTSD itself.

Sleep disorders, anxiety, arthritis, glaucoma, Crohn’s disease — these conditions don’t care that you live in a small town. They hit just as hard in Tipton as they do in Houston or Chicago. But in Tipton County, you have fewer options. There are no legal dispensaries. Your doctor might not be comfortable discussing cannabis. You can drive to Michigan where it’s legal, but that’s a four-hour round trip and you’re breaking federal law crossing state lines with it.

That’s why we’re here. OilWell Cannabis ships directly to Tipton County, Indiana. Our products arrive at your door via USPS within 2-3 business days, fully legal under the 2018 Farm Bill, with complete documentation and lab results. No medical card required. No qualifying conditions. Just age verification (21+) and a commitment to using these products responsibly.

Who Was Rick Simpson — And Why His Story Matters to Tipton County

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor. He wasn’t a scientist. He was a power engineer and maintenance worker — a blue-collar tradesman, much like many of the hardworking people in Tipton County who keep our farms, factories, and infrastructure running. His path to cannabis advocacy didn’t start in a lab. It started when the medical system failed him.

In 1997, Simpson fell from scaffolding at a hospital in Moncton, New Brunswick, and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications his doctors prescribed either didn’t help or made things worse. When he found that cannabis provided more relief than anything else, he asked his physician to support or prescribe it. The doctor refused .

Sound familiar? If you’re in Tipton County and you’ve ever asked a doctor about cannabis only to be dismissed, you’re experiencing the same pattern that drove Rick Simpson to take matters into his own hands.

Simpson’s interest deepened after he learned about a 1974 NIH-funded study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a cornerstone of his advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursue conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. Important context: No independent medical verification of this outcome has ever been published. No biopsy confirmation. No clinical follow-up in any peer-reviewed source. This was his personal testimony, not medical evidence .

But here’s why that story matters for Tipton County: Simpson’s experience reflects the desperation that drives people to seek alternatives when conventional medicine falls short. It’s the same desperation a cancer patient in Tipton feels when driving to Indianapolis for treatment that may or may not work. It’s the same desperation a veteran in Sharpsville feels when the VA’s prescription pad doesn’t stop the nightmares.

Simpson’s account is presented here as historically significant — the catalyst for a global movement — not as clinical proof. That’s the honest framing that most RSO websites won’t give you. We will.

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil. Operating from his property in Maccan, Nova Scotia, he made oil in large quantities and gave it away for free to cancer patients and others in his community. He charged nothing. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more .

His story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. Within cannabis communities, it was foundational. For many people worldwide — including many in Indiana who first learned about RSO through online forums — this film was their introduction to concentrated cannabis oil as medicine .

Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and again in 2009. He was charged with cultivation, possession, and trafficking. Eventually, facing continued legal pressure, he left Canada for Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad .

In 2012, he published Phoenix Tears: The Rick Simpson Story, detailing his personal experience, oil-making process, and philosophical views .

Throughout his public career, Simpson maintained that cannabis oil could cure cancer and many other diseases, and that pharmaceutical companies and government agencies were actively suppressing this knowledge. He framed his work as a fight against institutional corruption .

Important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement. We note it here without endorsement or dismissal because it’s relevant to understanding why RSO became culturally significant. But we also note what Simpson was not: he had no formal medical training, conducted no clinical trials, published no peer-reviewed research. His evidence was personal experience and testimonials, gathered informally with no controls, no verification, no imaging confirmation, and no long-term follow-up .

The Traditional RSO Protocol — And Why Tipton County Residents Need to Know Its Limitations

Simpson’s core treatment recommendation was a structured oral protocol: 60 grams of concentrated cannabis oil over approximately 90 days. This is what you’ll find if you search “RSO dosing” online. It’s what cancer patient forums in Indiana discuss. It’s what your neighbor might be doing. You need to understand exactly what this protocol entails — and its very real limitations.

The 60-Gram Protocol Breakdown

Goal: Consume 60 grams of concentrated, high-THC cannabis oil over about 90 days.

Week 1: Start with a dose about the size of half a grain of dry rice — roughly 10-15 milligrams of oil — taken three times daily (morning, afternoon, before bed). Total daily intake: 30-45 milligrams.

Weeks 2-5: Double the dose every four days. By the end of this escalation period, the target is approximately 1 gram (1,000 milligrams) of oil per day, divided into three roughly equal doses.

Weeks 5-12: Maintain the full dose of ~1 gram per day, divided into three doses of ~333 milligrams each, until all 60 grams are consumed.

Important context for evaluating this protocol in Tipton County:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or even well-documented case series evaluating this specific 60-gram/90-day protocol for any cancer type or any other condition. Zero. This is a critical gap that affects everyone considering this approach, whether you’re in Tipton County or Toronto.

• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content per gram varied widely depending on the starting plant material and extraction technique. A batch made from cannabis grown in someone’s basement in Kokomo would be completely different from a batch made from dispensary flower in Michigan.

• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil per day. Assuming 60-90% THC content, that’s 600-900 milligrams of delta-9 THC daily. For context, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20 milligrams per day. Simpson’s protocol delivered 30-450 times that amount.

• Real risks at these doses. Consuming 600-900 milligrams of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. A 2025 systematic review found consistent unfavorable associations between high-concentration THC products and psychosis, schizophrenia, anxiety, depression, and cannabis use disorder [15].

• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment — potentially in place of proven therapies — introduces harm beyond the oil itself. Delayed treatment for treatable cancers is a documented concern in alternative medicine.

If you’re a cancer patient in Tipton County currently undergoing treatment at IU Health or Community Howard Regional, please have an honest conversation with your oncologist before making any decisions about RSO. Our product is designed to complement medical care, not replace it.

What Traditional RSO Actually Was — The Product

Traditional RSO wasn’t a standardized medicine. It was a specific type of crude cannabis oil defined by Simpson’s method, not by lab specifications. Understanding what it actually was helps you evaluate what’s being sold today as “RSO” in Indiana and online.

Source material: Single high-THC indica strains, with no standardization. Simpson favored heavy, sedating indicas and recommended against sativas for cancer treatment. But there was no strain consistency — whatever he grew or sourced is what went into the oil.

Extraction solvent: Naphtha (a petroleum-based solvent, commercially available as lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic or carcinogenic compounds. This is a major safety issue for anyone considering DIY extraction in Tipton County.

Extraction process: Eight steps involving buckets, solvent washes, cheesecloth filtration, and rice cooker evaporation. The process is documented in the Rick Simpson section above. It’s crude, dangerous (fire risk with solvents), and completely uncontrolled.

Appearance: Nearly black, thick, tar-like oil with strong cannabis odor and possible solvent-residual smell. Difficult to handle at room temperature.

Cannabinoid profile: Fully decarboxylated, THC-dominant (60-90% estimated), with minor cannabinoids present only at whatever natural ratios the source strain contained. No ratio control, no lab verification.

Terpene content: Essentially none. The combination of solvent extraction and high-heat evaporation stripped terpenes out. Traditional RSO was a cannabinoid-only product, despite being derived from a terpene-rich plant.

Standardization and testing: None. Every batch was different. No Certificate of Analysis, no cannabinoid quantification, no contaminant screening.

Residual solvent risk: Significant. Incomplete solvent purging is difficult to verify without lab testing and leaves potentially harmful residues in the finished oil.

The bottom line for Tipton County residents: If you see “RSO” for sale online or in a Michigan dispensary, and it’s not from a company that publishes complete lab results showing cannabinoid breakdown, terpene profile, and safety testing, you’re buying a product that bears little resemblance to what Simpson actually made — and that may be a good thing, because Simpson’s original method had serious safety flaws.

The Evidence Question: What Science Actually Says About RSO and Cancer

This is the section most RSO websites won’t write. We will, because the people of Tipton County making life-and-death decisions deserve honesty.

Rick Simpson claimed RSO could cure cancer. He was adamant, consistent, and public about this claim throughout his advocacy career .

What Simpson was not: A scientist, physician, pharmacologist, or researcher. He had no formal medical training. He never designed, conducted, funded, or published a clinical trial. He never submitted results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and informally gathered testimonials — with no controls, no verification, no imaging confirmation, no long-term follow-up, and no blinding .

What the preclinical literature shows: In vitro studies demonstrate that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . Animal model studies show some tumor-growth inhibition in mice and rats treated with cannabinoids . These findings generate legitimate scientific interest and ongoing research.

What the preclinical literature does NOT show: These findings have NOT translated into proven human cancer cures. The gap between in vitro/animal results and human clinical outcomes is vast and well-documented across all oncology research. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer. Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been conducted, but they were exploratory, small, and did not produce results supporting cancer-cure claims .

Institutional positions:

• The U.S. National Cancer Institute (NCI) acknowledges that cannabinoids have been studied for potential anticancer effects in laboratory and animal models but does not endorse cannabis or cannabis oil as a cancer treatment .

• The U.S. Food and Drug Administration (FDA) has not approved any cannabis plant product for cancer treatment. The only FDA-approved cannabinoid-related products are for other specific indications: Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting [1].

• Health Canada has never approved RSO or cannabis oil as a cancer cure.

• The NIH National Center for Complementary and Integrative Health (NCCIH) states that the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea and vomiting, and appetite/weight-loss indications in HIV/AIDS — not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. His advocacy — however scientifically imprecise — helped create the political, cultural, and social conditions for the legal cannabis industry and cannabinoid research infrastructure that exists today. He brought concentrated cannabis oil to widespread public awareness, and the term RSO remains the most recognized name for full-spectrum cannabis extract .

What he overstated: The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it is not supported now. Encouraging patients — particularly cancer patients — to rely on RSO as a primary treatment in place of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine.

For Tipton County cancer patients: If you’re considering RSO, we urge you to maintain open communication with your oncologist at IU Health, Community Howard Regional, or wherever you receive treatment. Our product is designed to potentially help with symptom management — nausea, pain, sleep, anxiety — not to cure cancer. Please don’t delay or replace proven treatments based on anecdotal claims.

How Modern RSO Has Evolved — And Why Tipton County Benefits

The term “RSO” today is used loosely across the legal cannabis industry. Many products labeled as RSO bear little resemblance to what Simpson originally made. That’s not necessarily bad — it’s evolution.

Simpson himself has been critical of commercial products that use the RSO name while departing from his original method. He gave his oil away for free and urged people to make their own rather than buy from companies .

But here’s what can’t be disputed: Modern RSO has evolved substantially, and those changes directly benefit Tipton County residents.

Traditional RSO vs. Our Formulated RSO

Dimension	Traditional RSO (Simpson’s Method)	OilWell Formulated RSO (What We Ship to Tipton County)
Source material	Single high-THC indica strain, no standardization	Multi-cannabinoid blend from multiple sources, precisely controlled
Extraction method	Naphtha or isopropyl alcohol (toxic, non-food-grade)	Modern food-grade ethanol or CO₂ methods, solvent-free final product
Cannabinoid profile	THC-dominant (60-90%), uncontrolled, unmeasured	Seven defined cannabinoids at specific ratios, lab-verified
Terpene content	Destroyed by heat, essentially none	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets (553 mg/mL)
Lab testing	Not performed	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbes
Residual solvents	Significant risk with naphtha	Controlled and tested, well below FDA limits
Dosing precision	Approximate, syringe-based	Measured per mL with graduated dropper (0.1 mL increments)
Product formats	Single thick oil only	Sublingual oil and vape cartridge, format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — 1,500 mg THCa included as separate ingredient
Delta-9 THC dominance	60-90% of content	Only 90 mg in entire 30 mL bottle (3 mg/mL)
Evidence approach	Anecdotal, personal testimony only	Research-backed, evidence-weighted, peer-reviewed citations

Five Ways Our Formula Diverges From Simpson’s — And Why That Matters for Tipton County

1. Multi-cannabinoid approach. Simpson used whatever single strain he grew. Our formula intentionally includes seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29]. For Tipton County residents dealing with complex conditions like fibromyalgia or PTSD that involve multiple pathways (pain, inflammation, sleep, mood), a single-cannabinoid approach often falls short.

2. Terpene preservation. Traditional RSO had no terpenes due to heat destruction. Our formula includes live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Terpene bioactivity is plausible and supported at preclinical levels, though human clinical confirmation is still developing [20]-[28]. The sensory experience matters too — our RSO smells and tastes like cannabis should, not like tar.

3. THCa as a separate ingredient. Simpson’s oil was fully decarboxylated. Our sublingual formula includes 1,500 mg of THCa — the acidic, non-psychoactive precursor to THC. The THCa literature suggests potentially relevant non-psychoactive bioactivity (anti-inflammatory via COX-2 inhibition, neuroprotective via PPARγ agonism) that is lost when THCa converts to THC [12]. More importantly for Tipton County residents who work, drive, or parent: THCa stays non-psychoactive until YOU choose to heat it.

4. Reduced delta-9 THC dominance. Simpson’s oil was 60-90% delta-9 THC. Our formula contains only 90 mg of delta-9 THC in the entire bottle. We distribute the remaining cannabinoid content across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), CBN (750 mg), and CBC (750 mg). This reflects the broader cannabinoid research landscape rather than a single-compound dominance model. For Tipton County residents concerned about impairment, this is a game-changer.

5. Product format innovation. Simpson envisioned only one format: oral oil from a syringe. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulations. Different delivery routes have different pharmacokinetic profiles [14], and Tipton County residents have different needs — some need sustained relief through the day, others need fast relief for breakthrough pain or panic.

Solvent Safety — Why Traditional RSO Production Is Dangerous

Traditional RSO used naphtha or isopropyl alcohol — neither food-grade. Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging leaves harmful residues.

Modern cannabis extraction uses food-grade ethanol or supercritical CO₂. Our product isn’t even an extraction — it’s a formulated blend of individual cannabinoid distillates and isolates combined in a controlled environment. No naphtha. No isopropyl. No butane. No extraction solvents in the finished product.

We use organic MCT oil as the carrier. MCT oil is a food-grade lipid that facilitates sublingual absorption and provides a neutral taste — a huge improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers:

• Cannabinoid potency (HPLC/UHPLC analysis, ±2% accuracy)
• Terpene profile
• Pesticides (400+ compound screening via LC-MS/MS and GC-MS/MS)
• Heavy metals (arsenic, cadmium, lead, mercury below FDA limits via ICP-MS)
• Residual solvents (headspace GC, FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and through our website.

The Decarboxylation Choice — Patient-Controlled Potency (Critical for Tipton County)

Traditional RSO was always fully decarboxylated and always psychoactive. Our formula contains 1,500 mg of THCa that YOU control. This creates three distinct usage options:

Option 1 — Raw, no heat (Non-psychoactive): All 1,500 mg stays as THCa. Completely non-psychoactive. Compatible with work, driving, parenting, daytime use with zero impairment. The THCa evidence suggests anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. For Tipton County residents who operate farm equipment, work at Cook Medical in nearby Bloomington, or drive the kids to school in Tipton, this is essential.

Option 2 — Fully activated, home decarboxylation (Psychoactive): Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC. Combined with 6,000 mg delta-8 THC, this achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because the conversion happens at your discretion after purchase.

Option 3 — Vape, auto-decarboxylation (Instant): Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available.

Conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (reflecting the loss of a CO₂ molecule).

This design puts the potency decision entirely in your hands — aligning with Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry rather than rhetoric.

The True Story of OilWell Cannabis — From a Paralyzed Dog to Serving Tipton County

Our company wasn’t born in a boardroom. It was born in a moment of desperation, love, and scientific discovery that happened because a man refused to give up on his dog.

Bentley — The Dog Who Started It All

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But to understand why our formula is different — why it contains seven cannabinoids instead of one, why we preserve THCa, why we publish our formula openly — you have to know Bentley.

Bentley was more than a pet. He was family, a companion who stood by Colin through the toughest times of growing up in McAllen, Texas, right across from the dangerous Reynosa border region. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. The vet said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything.

A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience — but it was recreational. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It was not a cure, but it was a lifeline. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play.

From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration → led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → led to CBC’s role in neurogenesis
• Glaucoma → led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Bentley’s journey was Colin’s entry into cannabis beyond just getting high. It became a mission to create real solutions that help alleviate pain and suffering, not just for pets but for people. Bentley’s story is the foundation of OilWell Cannabis, driving our commitment to quality, innovation, and compassionate care.

Colin’s Personal Battle — PTSD, Benzo Addiction, and Quitting Xanax Cold Turkey

Colin also knows pharmaceutical dependence personally. He struggled with severe PTSD and benzodiazepine addiction after his experiences growing up in the violent Borderplex region and transitioning from the illegal cannabis world to legitimate business.

When he decided to break free from Xanax, he did it cold turkey — a feat notoriously difficult and dangerous — using the cannabinoid knowledge he’d developed keeping Bentley alive. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, we also offer Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

From Underground to Legitimate — A Houston Success Story

Colin grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. He later became a formally trained software engineer and did custom development work for Baylor College of Medicine in the Texas Medical Center.

That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines OilWell’s approach. While Rick Simpson had no medical training, Colin has both plant knowledge and experience working at one of the most prestigious medical institutions in America.

The result: a company that Texans trust and that ships nationwide, including to Tipton County, Indiana.

Why ABC13 Houston Featured Us Seven Times

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving America’s fourth-largest city — featured Colin and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

No other Houston cannabis operator appears with that frequency or across that breadth of subject matter.

The features spanned:

• Texas CBD business boom (September 2019)
• National decriminalization efforts (March 2021)
• Delta-8 THC legal analysis (May 2021)
• COVID-19 community health leadership — $35,000 product giveaway (August 2021)
• Delta-8 ban impact and proactive compliance (October 2021)
• Biden marijuana pardon and personal conviction history (October 2022)
• Texas marijuana law changes and industry “Renaissance” (April 2023)

Key quotes that define our philosophy:

September 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 2021: “People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.”

May 2021: Steve Campion asked, “Why would someone want to smoke that?” Colin replied: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* That radical honesty on mainstream television — with the expletive preserved by the network — became one of Colin’s most iconic moments.

October 2021: When Texas banned Delta-8 overnight, Colin had already removed all products from shelves, warning other operators who were unknowingly shipping Schedule I narcotics: “It’s disappointing, but I’m not going to lose my customers and business are going to want our expertise on how to continue thriving in the industry.”

October 2022: Revealing his personal marijuana conviction history during the Biden pardon coverage: “I would love to see people not get hurt for this anymore.” This transforms every quote that came before — Colin is not an outside entrepreneur who saw a business opportunity. He is someone who lived the consequences and built a legal business to prove the industry could operate with integrity.

April 2023: On the 4/20 special: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

These features are not marketing materials. They are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as the most credible voice in Houston’s legal cannabis industry. That is recognition that cannot be purchased — it can only be earned.

How Our RSO Formula Connects to Science — Evidence for Tipton County Residents

Every cannabinoid and terpene in our formula has its own evidence profile. We’re not asking you to take our word for it. We’re showing you the research and letting you decide.

Our Research Methodology

We prioritize sources in this order:

1. Human clinical evidence
2. Systematic reviews and meta-analyses
3. NIH and other institutional summaries
4. Mechanistic or preclinical literature (when human data are sparse)

This weighting matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and early translational studies [1]-[29].

Institutional Baseline from NIH and NCCIH

The National Center for Complementary and Integrative Health (NCCIH, part of NIH) states that the strongest established cannabinoid evidence is for:

• Certain rare epilepsies
• Chemotherapy-related nausea and vomiting
• Appetite or weight-loss indications in HIV/AIDS

NCCIH notes only modest evidence for chronic pain and multiple-sclerosis-related symptoms, with many other claimed uses still in early-stage research [1].

Safety concerns highlighted by NIH:

• Impairment and motor vehicle crash risk
• Cannabis use disorder
• Pregnancy-related concerns
• Contamination or labeling inaccuracy
• THC-vape lung-injury concerns
• Liver-related adverse effects with CBD
• Drug-drug interactions [1]

Critical point: The FDA has not approved the cannabis plant itself for medical use, although purified CBD (Epidiolex) and synthetic THC-like drugs have specific approvals [1].

Detailed Evidence Profiles — What Each Compound Does (And Doesn’t Do)

CBD (Cannabidiol) — 4,500 mg in our sublingual formula

Strongest evidence: Purified CBD has the most credible human evidence, especially for seizure disorders. This is the clearest major indication acknowledged by institutional literature [1][2].

Anxiety: A 2024 systematic review and meta-analysis of 316 participants across eight studies reported statistically significant anxiolytic effects, but authors stressed the clinical sample remains limited and more trials are needed [3].

Pain: A 2024 systematic review concluded that the pain literature is promising but heterogeneous, with trial quality limiting confidence in broad analgesic claims [4].

Sleep: A 2023 insomnia review found the literature methodologically weak, with many studies relying on subjective measures and few objective sleep assessments [5].

Safety: A 2023 systematic review found a real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug interactions [1].

Bottom line for Tipton County: CBD is the most evidence-developed non-intoxicating cannabinoid, but strong evidence is concentrated in a few specific indications (seizures) rather than broad wellness claims. If you’re using CBD for pain, anxiety, or sleep in Tipton County, you should know the evidence is promising but not definitive.

CBG (Cannabigerol) — 3,000 mg in our formula

Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids and appears pharmacologically distinct from THC and CBD. It interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling, making it mechanistically interesting but not yet clinically established [7].

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses or preclinical findings, not mature human therapeutic conclusions [7][8].

Caution: A 2021 pharmacology review noted that CBG is already being sold commercially while the evidence base remains thin, meaning claims frequently outrun the science [7].

Bottom line for Tipton County: CBG is a promising minor cannabinoid with limited clinical validation. We include it because Bentley’s neurodegeneration required it, and because the preclinical data justifies further study. But we won’t overstate it.

Delta-8 THC — 6,000 mg in our formula

Evidence profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 THC is a partial CB1 agonist with cannabimimetic activity, but appears less potent than delta-9 THC, likely due to weaker CB1 affinity [9].

Public health literature: A 2023 scoping review found most delta-8 evidence comes from animal studies, product chemistry, use reports, and public-health concerns rather than strong human trials. It noted reports of adverse consequences and emphasized regulatory and product-quality concerns [10].

Manufacturing context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which raises product-byproduct and lab-testing questions [11].

Bottom line for Tipton County: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity but incomplete human safety characterization. Our formula includes it at significant levels (6,000 mg) because the evidence suggests therapeutic potential with possibly milder psychoactive effects than delta-9 THC. But we provide the safety context that our competitors won’t.

THCa (Tetrahydrocannabinolic Acid) — 1,500 mg in our formula

Evidence profile: Important chemically and formulation-wise, but still low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor of THC and represents a large share of THC-related content in raw plant material. It decarboxylates into THC during heating and can change over time during storage and processing [12].

Psychoactivity: THCa itself does not produce psychoactive effects associated with THC, but this distinction only holds if the molecule stays acidic and isn’t substantially decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not established human outcomes [12].

Bottom line for Tipton County: THCa is best understood as a precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Our patient-controlled potency model lets you choose whether to keep it raw (non-psychoactive) or decarboxylate it (psychoactive). No other RSO product gives you this choice.

Delta-9 THC — 90 mg in our entire 30 mL bottle

Evidence profile: Strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden [1][13]-[15].

Institutionally supported uses: NCCIH identifies THC-containing medicines as relevant to chemotherapy-related nausea/vomiting, appetite/weight loss in HIV/AIDS, and some multiple-sclerosis- and pain-related outcomes [1].

Pain evidence: A 2022 systematic review found cannabis-based products with high THC content or comparable THC:CBD ratios may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation due to adverse events [13].

Pharmacokinetics: Inhaled THC produces effects within seconds to minutes, peaks in 15-30 minutes, and tapers over a few hours. Oral THC has later onset, later peak, and longer duration [14]. Our sublingual oil falls between these extremes — 15-45 minute onset, 4-6 hour duration.

Mental health risk: A 2025 systematic review found consistent unfavorable associations between high-concentration THC products and psychosis, schizophrenia, anxiety, depression, and cannabis use disorder [15].

Broader safety: Institutional literature describes anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, and vape-related lung injury concerns [1][14][15].

Bottom line for Tipton County: Delta-9 THC has legitimate therapeutic relevance but carries intoxication, psychiatric, and dose-related safety liabilities. Our formula contains only 90 mg total — the minimal amount to maintain Farm Bill compliance while providing a baseline level for potential entourage effects. This is dramatically safer than traditional RSO’s 600-900 mg per day.

CBN (Cannabinol) — 750 mg in our formula

Evidence profile: Weak human evidence; marketing has moved ahead of the data [12][16][17].

Marketing vs. reality: CBN is widely marketed for sleep and sedation, but clinical support is far thinner than the market suggests [16][17].

Best direct review: A 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims [16].

Broader sleep literature: A 2024 updated review concluded that overall cannabinoid sleep research still doesn’t match real-world use scale, and the need for better-designed trials remains substantial [17].

Bottom line for Tipton County: CBN is one of the clearest examples where cultural reputation is stronger than clinical evidence. We include 750 mg (25 mg per mL at our 553 mg/mL concentration) because at 1-2 mL doses, this delivers 25-50 mg CBN — the range investigated in recent literature [16][17]. But we present it honestly: the evidence is emerging, not established.

CBC (Cannabichromene) — 750 mg in our formula

Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].

Pharmacology: A 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, highlighting antinociceptive, antibacterial, and anti-seizure areas as interesting research targets [18].

Older literature: Review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance, but these aren’t strong patient-facing claims [19].

Safety caveat: The 2024 CBC review explicitly notes that over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line for Tipton County: CBC belongs in the category of scientifically credible minor cannabinoids that deserve more research, not in the category of already-validated clinical actives. We’re including it because Bentley’s dementia journey suggested neurogenesis potential, but we won’t overstate the evidence.

Terpene Science — The Aromatic Dimension

Terpene claims need even stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. The 2024 entourage-effect review makes this especially important: terpene bioactivity is plausible and sometimes compelling, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene — Citrus-bright

Evidence: Review and preclinical; safety literature is useful [20]-[22].

Potential activity: A 2021 review describes limonene as multifunctional with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory possibilities, but most claims come from nonhuman or non-cannabis literature [21].

Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing [22].

Bottom line for Tipton County: Limonene is biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative.

Myrcene

Evidence: Mostly preclinical; very limited human evidence [20][23].

Research: A 2021 review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties and discusses possible mechanisms, but explicitly states human studies are lacking [23].

Interpretation caution: Myrcene is often invoked as a proven sedating terpene that explains “couch-lock.” That claim is stronger than the human evidence supports [20][23].

Bottom line for Tipton County: Myrcene is a plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof.

Caryophyllene — Pepper/spice, CB2 agonist

Evidence: Among the most mechanistically interesting terpenes because of direct cannabinoid-system relevance, but still mostly preclinical [24].

Why it stands out: A 2021 review describes beta-caryophyllene as a selective CB2 receptor agonist, unusual and especially relevant when discussing cannabis terpenes pharmacologically rather than just aromatically [24].

Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions are discussed, but human clinical confirmation remains limited [24].

Bottom line for Tipton County: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but it still shouldn’t be described as clinically proven.

Pinene — Forest-fresh

Evidence: Promising preclinical literature, weak human confirmation [20][25].

Brain-health framing: A 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, and neuroprotective signals justifying future study, but emphasized well-designed clinical trials are lacking [25].

Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses, not settled facts [20][25].

Bottom line for Tipton County: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory.

Linalool — Floral, lavender

Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

Research: Linalool is repeatedly discussed in relation to stress, mood, and brain-health pharmacology. The 2021 brain-health review found enough preclinical signal to justify continued investigation while emphasizing the lack of robust human trials [26].

Safety note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

Bottom line for Tipton County: Linalool is scientifically credible as a bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises.

Humulene — Earthy, woody

Evidence: Translationally interesting, but still early [20][27].

Scoping-review findings: A 2024 scoping review analyzed 340 articles and found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Interpretation caution: Those findings are valuable for hypothesis generation but don’t yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

Bottom line for Tipton County: Humulene is an interesting terpene research target, but remains far from clinically settled.

Terpinolene — Piney, fruity, sparkling

Evidence: One of the least clinically characterized terpenes in our profile [20][28].

Systematic-review findings: A 2021 terpinolene review screened 2,449 records, included 57 studies, and concluded terpinolene has reported biological effects but the evidence base is still dominated by in silico, in vitro, and animal studies [28].

Bottom line for Tipton County: Terpinolene is biologically interesting, but especially underdeveloped clinically.

Research Limits and Interpretation Rules for Tipton County Readers

1. The evidence base is highly uneven. CBD and delta-9 THC support the most detailed human-facing statements; the rest require more caution [1]-[29].

2. Data types aren’t interchangeable. Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. One common error is letting evidence from one category stand in for another.

3. Minor cannabinoids are commercially interesting because they’re underexplored. That also means claims around them often become inflated.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect real-world products [1][10][11][14].

5. THCa chemistry changes with storage and heating. Storage and heating can change actual exposure by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid — Staying Honest with Tipton County

Overstatement: CBN is a clinically proven sleep cannabinoid.
More accurate: The specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

Overstatement: Terpenes in general have proven entourage effects in patients.
More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

Overstatement: THCa is always nonpsychoactive.
More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

Overstatement: Delta-8 THC is safe because it’s hemp-derived.
More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Our Product Formulas — Complete Transparency for Tipton County

We publish our complete formulas publicly. If you can’t afford our products, you can source the ingredients and make your own version. This is our open-source commitment — the modern evolution of Rick Simpson’s free-distribution ethos.

RSO Sublingual Oil — $129.99

Free shipping to Tipton County, Indiana

Cannabinoid	Amount (mg)
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle (1 fl oz)
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Dosing tool: Graduated dropper for precise 0.1 mL increments
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (sublingual partially bypasses first-pass liver metabolism)
• Doses per bottle: Approximately 40-60 depending on serving size

Why this matters for Tipton County: At 553 mg/mL, this is one of the most concentrated legal cannabinoid products available. For severe chronic pain patients in Tipton County who’ve been failed by opioids, this concentration means you need less volume to achieve potential therapeutic effects. For cancer patients dealing with chemo side effects, the multi-cannabinoid profile addresses multiple symptoms simultaneously. For seniors on fixed incomes in Tipton County, the 40-60 dose count means it lasts.

RSO Vape Cartridge — $49.99

Free shipping to Tipton County, Indiana

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram cartridge
• Battery compatibility: 510-thread universal
• Onset: 1-2 minutes (fastest cannabinoid delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique)
• Auto-decarboxylation: Vaping at 400-450°F instantly converts THCa to delta-9 THC

Why this matters for Tipton County: For breakthrough pain that hits suddenly while you’re working in the fields or at a factory in Tipton County, waiting 45 minutes for sublingual onset isn’t practical. The vape delivers relief in 1-2 minutes. For panic attacks or acute nausea during chemo, this speed can be life-changing.

When to Use Each Format — A Tipton County Guide

Use Case	Recommended Format	Why It Works for Tipton County
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset gets you back to work quickly
Sustained relief (chronic pain, sleep)	Sublingual Oil	4-6 hour duration covers you through the night or workday
Maximum bioavailability	Sublingual Oil	13-19% absorption means more medicine, less waste
Portability/discretion	Vape	Compact, no measuring, looks like any vape pen in Tipton County
Precise dosing	Sublingual Oil	Graduated dropper lets you dial in exact doses for titration
Daytime non-psychoactive	Sublingual Oil (raw, no heat)	THCa stays inactive, zero impairment for operating equipment
Nighttime psychoactive	Sublingual Oil (decarbed) or Vape	Activated THCa + delta-8 THC for sleep and severe symptom relief

Condition-Specific Usage Context for Tipton County Residents

Critical disclaimer: These usage contexts are informed by cannabinoid research cited above and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. Our products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

Pre-chemo: 0.5-1.0 mL sublingual oil approximately 1 hour before treatment at IU Health or Community Howard Regional.

Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset) during or after chemo sessions.

Post-chemo: 0.5 mL sublingual oil every 6 hours as needed for ongoing nausea management.

Sleep support during treatment: 1.0-2.0 mL sublingual oil before bed (delivers 25-50 mg CBN for sleep architecture support).

Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea/vomiting evidence [1][13], CBD anxiolytic buffering [3].

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy) — Especially Relevant for Tipton County

Daytime functional relief: 0.3-0.5 mL raw sublingual oil (non-psychoactive) for anti-inflammatory cannabinoid exposure without impairment. Perfect for working at AutoAlliance in Tipton, operating farm equipment, or driving to Kokomo.

Nighttime relief: 0.5-1.0 mL decarboxylated sublingual oil — combines pain relief with CBN sleep support for restorative rest.

Breakthrough pain: Vape as needed for rapid onset when pain spikes unexpectedly.

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support for Tipton County Residents

Before bed: 1.0-2.0 mL sublingual oil.

At 2.0 mL, this delivers 50 mg CBN — the dosage level investigated in recent sleep literature [16][17].

At 1.0 mL, this delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance in published research [16][17].

Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature [17].

Anxiety and Stress — Common in Rural Indiana

Daytime functional relief: 0.3 mL raw sublingual oil — CBD and CBG address anxiety-related pathways without psychoactive impairment.

Nighttime: 1.0 mL sublingual oil — full cannabinoid profile including CBN for sleep architecture.

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20].

General Titration Principle for All Tipton County Users

Start low, go slow. Begin with 0.25-0.5 mL sublingual oil and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

If you’re new to cannabinoids, consider keeping a journal for the first week noting dose, time, effects, and side effects. This helps you find your optimal dose faster.

How to Order OilWell RSO in Tipton County, Indiana

We serve Tipton County residents through multiple delivery options designed for rural accessibility:

Nationwide Shipping to Tipton County

• Carrier: USPS Priority Mail (2-3 business days) or FedEx/UPS Ground (3-5 days)
• Cost: Flat-rate shipping calculated at checkout ($5-15 depending on order size)
• Discreet packaging: No cannabis branding visible on exterior
• Tracking: Provided for all orders
• Temperature-stable packaging: Ensures product integrity during Indiana summers
• Signature-required option: Available for security

How it works:

1. Visit https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
2. Add RSO Sublingual Oil ($129.99) and/or Vape Cartridge ($49.99) to cart
3. Enter your Tipton County address (Sharpsville, Kempton, Tipton, or rural route)
4. Age verification (21+) required at checkout
5. Payment processed securely
6. Package ships within 24 hours (Monday-Saturday)
7. Track via email notification
8. Delivered to your Tipton County door

What Your Package Includes

• Product in child-resistant packaging
• Complete Certificate of Analysis (COA) for your specific batch
• Receipt with legal documentation showing Farm Bill compliance
• Insert with dosing guidance and safety information
• Our direct contact information: (832) 416-2816 and [email protected]

Payment Options for Tipton County

• All major credit/debit cards
• No cash on delivery (Indiana banking regulations)
• No payment plans available
• No insurance coverage (cannabis products are not FDA-approved)

International Shipping Note

While we ship internationally, Tipton County residents should note that Indiana law permits hemp-derived products under the Farm Bill. Our products are legal to purchase, possess, and use in Indiana. We ship from Texas to Indiana daily without issues.

Open-Source Formulas — Make Your Own RSO in Tipton County

If you can’t afford $129.99 for our sublingual oil, we still want you to have access. That’s why we publish our complete formula. You can source the individual cannabinoid distillates and isolates from reputable suppliers (we recommend only verified, lab-tested sources) and make your own version.

This is a direct echo of Rick Simpson’s original ethos. He gave his oil away for free. We sell a professionally manufactured, lab-tested product for those who want it, and publish the complete recipe for those who want to make it themselves.

CBD Golden Paste Recipe for Pets — The Original Open-Source Formula

Before we published the RSO formula, we published the recipe that saved Bentley. If you’re in Tipton County and have a pet facing similar challenges, you can make this today:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size; consult your Tipton County veterinarian)

Instructions:

1. Mix turmeric and water in saucepan, stir over low heat until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir until thoroughly mixed
3. Allow to cool, transfer to jar with lid
4. Store in refrigerator up to two weeks
5. Mix small amount with pet’s food once or twice daily
6. Always consult your Tipton County veterinarian before starting any new supplement regimen

This recipe demonstrates that our open-source ethos is foundational behavior, not marketing strategy. We gave away the formula that saved Bentley before we gave away the formula for people.

Legal Compliance for Tipton County, Indiana

Age Requirements

• Must be 21+ to purchase RSO products
• Age verified at checkout and upon delivery

THC Content Compliance

• Our products contain less than 0.3% delta-9 THC by dry weight
• Farm Bill compliant (Agricultural Improvement Act of 2018)
• All cannabinoids hemp-derived
• Legal under federal law and Indiana state law

FDA Disclaimers

• Not evaluated by the Food and Drug Administration
• Not intended to diagnose, treat, cure, or prevent any disease
• Consult your healthcare provider before use
• Individual results may vary

Safety Warnings for Tipton County Users

• May cause drowsiness or impairment
• Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids
• Consult physician if pregnant or nursing
• Keep out of reach of children and pets
• Store in cool, dark place away from heat (to control THCa conversion)

Legal Responsibility

• Buyer is responsible for checking local Tipton County and Indiana laws
• Company assumes no legal responsibility for customer’s use or decarboxylation decisions
• Void where prohibited by law (currently legal in all 50 states under Farm Bill, but laws change)

Why Tipton County Should Trust OilWell Cannabis

Our Media Record — Verified by ABC13 Houston

Seven features across four years. Five different reporters. Topics spanning business, law, medicine, community health, and politics. This isn’t purchased PR. This is earned credibility from a major-network affiliate that repeatedly identified Colin Valencia as Houston’s most credible cannabis voice.

Key credibility markers:

• September 2019: First feature, establishing the “no snake oil” philosophy
• August 2021: $35,000 product donation to encourage COVID vaccination (community action)
• October 2021: Proactive Delta-8 removal before enforcement (ethical leadership)
• October 2022: Personal conviction history revealed (authenticity and personal stakes)
• April 2023: “Renaissance” framing at 4/20 (industry leadership)

Our Technical Credentials

• Colin’s software engineering background and Baylor College of Medicine custom development work
• Medical-grade precision applied to cannabis formulation
• Ten years of real-world formulation testing on Bentley (not just lab rats)
• Colin’s personal experience with PTSD and benzo withdrawal (lived experience)

Our Product Quality

• Solvent-free production
• Organic MCT oil carrier
• Full third-party testing (potency, terpenes, pesticides, heavy metals, residual solvents, microbes)
• COAs available for every batch
• 16,590 mg total cannabinoids per bottle — unmatched concentration
• Seven-cannabinoid + seven-terpene profile for true entourage potential

Our Accessibility for Tipton County

• No medical card required
• Ships directly to your Tipton County door (rural routes included)
• Free shipping on qualifying orders
• Same-day shipping (orders placed before 2 PM CST ship same day)
• Customer service that answers the phone: (832) 416-2816

Practical Takeaways for Tipton County — What This Means for You

• CBD and delta-9 THC are the most evidence-developed actives in our formula
• Delta-8 THC is not trivial; it’s psychoactive with less robust safety characterization than delta-9 THC
• THCa meaningfully changes with processing; our patient-controlled model lets you decide
• CBG, CBN, CBC are scientifically credible but clinically immature compared to CBD and THC
• Terpenes are likely relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully

References — The Science Behind Our Claims

Rick Simpson Sources

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

Cannabinoid and Terpene Research

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026.
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Final Thoughts for Tipton County

We wrote this guide because we believe the people of Tipton County deserve better than hype. You deserve to know exactly what’s in your medicine, what the science actually says, and how to use it safely and effectively.

Whether you’re a cancer patient at IU Health looking for nausea relief, a veteran in Tipton struggling with PTSD, a farmer dealing with chronic back pain, or a caregiver searching for options when doctors have run out of answers — we’re here. Not with miracle claims, but with the best-formulated, most transparently documented, legally compliant RSO available anywhere.

Our formula is the result of a decade of real-world testing, first on a dog named Bentley, then on our founder’s own PTSD, then refined through medical-grade precision. It’s backed by 29 peer-reviewed citations. It’s validated by seven major-network news features. And it’s shipped directly to your door in Tipton County within 2-3 business days.

Call us: (832) 416-2816
Email: [email protected]
Order online: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Thank you for taking the time to read this complete guide. We hope it helps you make an informed decision about whether RSO is right or wrong for you. As Colin said back in 2019 on ABC13: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot.”

That’s exactly what we’re giving you: the best possible version. The most honest education. The most transparent formula. And a product that can legally ship to Tipton County, Indiana, today.

Bentley got up and walked. We hope this guide helps you take your next step too.